@abstract
In a study (see my reply), authors have successfully created bacteria capable of detecting the KRASG12D mutation in colorectal cancer. While DNA sequencing is certainly an easier way to detect such mutation, these bacteria have the potential to be further engineered to deliver treatment precisely where it's needed.